Clarity Pharmaceuticals (ASX: CU6) Secures Historic FDA Breakthrough Status as US$2 Billion Cancer Imaging Opportunity Takes Shape
Clarity Pharmaceuticals ASX: CU6 has achieved a major regulatory milestone, becoming the first company to receive US Food and Drug Administration FDA Breakthrough Therapy designation for a P...